CN Stock MarketDetailed Quotes

600196 Shanghai Fosun Pharmaceutical

Watchlist
  • 25.90
  • -0.13-0.50%
Market Closed Dec 20 15:00 CST
69.19BMarket Cap32.74P/E (TTM)

Shanghai Fosun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
0.69%30.91B
-4.36%20.46B
-6.56%10.16B
-5.81%41.4B
-2.92%30.7B
0.22%21.4B
4.68%10.87B
12.66%43.95B
16.91%31.62B
25.93%21.35B
Operating revenue
0.69%30.91B
-4.36%20.46B
-6.56%10.16B
-5.81%41.4B
-2.92%30.7B
0.22%21.4B
4.68%10.87B
12.66%43.95B
16.91%31.62B
25.93%21.35B
Other operating revenue
----
-8.33%218.83M
----
-14.93%488.71M
----
3.67%238.71M
----
66.24%574.48M
----
57.70%230.25M
Total operating cost
-3.04%29.36B
-5.93%19.41B
-5.70%9.52B
-0.15%41.28B
2.86%30.28B
5.10%20.63B
4.19%10.1B
11.47%41.35B
15.80%29.44B
23.52%19.63B
Operating cost
0.70%15.89B
-2.20%10.46B
-4.10%5.08B
-6.80%21.6B
-6.70%15.78B
-7.60%10.7B
-9.67%5.29B
14.53%23.17B
24.03%16.91B
40.23%11.58B
Operating tax surcharges
18.12%233.83M
19.37%164.22M
37.93%92.44M
19.08%271.26M
20.13%197.96M
26.88%137.57M
25.41%67.02M
-2.85%227.8M
-4.66%164.78M
-5.83%108.43M
Operating expense
-8.78%6.59B
-15.87%4.27B
-10.93%2.24B
5.90%9.71B
11.23%7.23B
21.46%5.07B
21.59%2.52B
0.77%9.17B
-0.94%6.5B
-0.86%4.18B
Administration expense
-0.77%3.14B
0.95%2.06B
1.13%1B
14.28%4.37B
20.61%3.17B
21.77%2.05B
25.25%991.09M
18.63%3.83B
16.73%2.63B
14.66%1.68B
Financial expense
13.03%854.56M
7.97%588.83M
7.26%280.22M
52.04%984.32M
99.46%756.08M
107.78%545.37M
144.12%261.26M
39.52%647.4M
-3.66%379.07M
-7.25%262.47M
-Interest expense (Financial expense)
12.68%1.07B
17.60%709.55M
22.14%348.09M
37.46%1.32B
35.63%947.67M
37.47%603.38M
37.57%285.01M
17.17%963.81M
10.54%698.73M
4.32%438.91M
-Interest Income (Financial expense)
-5.31%-279.71M
-10.19%-188.97M
-10.60%-99.67M
-28.66%-363.65M
-34.00%-265.61M
-44.82%-171.49M
-64.43%-90.12M
-20.90%-282.63M
-13.59%-198.22M
-1.56%-118.42M
Research and development
-16.07%2.65B
-12.77%1.86B
-14.38%829.57M
1.02%4.35B
10.22%3.16B
16.81%2.13B
19.66%968.87M
12.11%4.3B
18.60%2.86B
16.98%1.83B
Credit Impairment Loss
33.24%-54.47M
34.39%-38.04M
-32.24%-16.41M
-101.82%-131.93M
-133.73%-81.58M
-153.61%-57.98M
-87.81%-12.41M
11.68%-65.37M
-71.58%-34.9M
-54.42%-22.86M
Asset Impairment Loss
85.92%-40.95M
77.99%-20.17M
144.64%5.89M
19.36%-219.74M
-210.83%-290.9M
-22.93%-91.66M
-2,158.02%-13.18M
67.17%-272.49M
62.00%-93.59M
64.04%-74.57M
Other net revenue
-46.74%1.56B
-54.40%875.35M
-40.96%386.54M
55.61%3.19B
111.83%2.93B
137.03%1.92B
239.14%654.7M
-53.21%2.05B
-55.10%1.38B
-64.29%809.8M
Fair value change income
-113.18%-106.25M
-172.90%-282.4M
86.36%-20.14M
82.89%-427.38M
141.76%806.34M
127.49%387.37M
89.13%-147.61M
-809.16%-2.5B
-245.96%-1.93B
-219.16%-1.41B
Invest income
-31.33%1.5B
-27.94%1.06B
-56.19%335.56M
-20.01%3.5B
-28.53%2.18B
-32.02%1.47B
-49.17%765.9M
-5.32%4.38B
65.13%3.05B
85.12%2.17B
-Including: Investment income associates
-18.80%1.21B
-17.70%841.32M
-9.83%330.32M
19.06%2.18B
22.55%1.5B
27.94%1.02B
14.94%366.34M
2.57%1.84B
-7.60%1.22B
-3.94%799.02M
Asset deal income
-60.10%2.51M
-10.94%716.94K
185.51%434.1K
-95.57%5.56M
-95.50%6.3M
-52.88%804.99K
-173.65%-507.68K
914.61%125.6M
2,026.44%140.1M
-40.15%1.71M
Other revenue
-14.78%258.89M
-26.05%153.48M
29.93%81.22M
20.66%463.54M
22.92%303.79M
40.75%207.54M
24.13%62.51M
17.18%384.15M
38.44%247.15M
10.28%147.45M
Operating profit
-7.02%3.11B
-28.08%1.93B
-28.43%1.02B
-28.97%3.31B
-6.14%3.34B
6.17%2.68B
61.11%1.43B
-26.11%4.66B
-24.23%3.56B
-24.07%2.53B
Add:Non operating Income
-30.29%34.57M
19.21%28.86M
65.62%9.31M
61.10%57.12M
195.83%49.59M
178.55%24.21M
-13.10%5.62M
23.72%35.46M
-27.44%16.76M
-58.50%8.69M
Less:Non operating expense
-28.93%70.59M
-47.53%26.94M
-74.47%12.25M
-15.01%100.06M
-51.89%99.33M
-71.94%51.35M
224.95%48M
-59.20%117.73M
267.97%206.48M
311.80%183.02M
Total profit
-6.71%3.07B
-27.27%1.93B
-26.46%1.02B
-28.63%3.26B
-2.33%3.29B
12.89%2.66B
57.80%1.38B
-24.30%4.57B
-27.76%3.37B
-28.81%2.35B
Less:Income tax cost
-13.40%553.05M
-37.49%381.47M
-14.16%232.2M
-41.06%369.5M
4.43%638.65M
19.87%610.24M
11.16%270.51M
-41.21%626.92M
-16.37%611.54M
-7.55%509.09M
Net profit
-5.10%2.52B
-24.23%1.55B
-29.44%786.22M
-26.66%2.9B
-3.83%2.65B
10.96%2.05B
75.70%1.11B
-20.67%3.95B
-29.87%2.76B
-33.06%1.84B
Net profit from continuing operation
-5.10%2.52B
-24.23%1.55B
-29.44%786.22M
-26.66%2.9B
-3.83%2.65B
10.96%2.05B
75.70%1.11B
-20.67%3.95B
-29.87%2.76B
-33.06%1.84B
Less:Minority Profit
36.99%507.88M
21.36%324.93M
38.66%176.49M
134.84%508.8M
14.66%370.74M
-12.93%267.75M
-28.33%127.28M
-12.48%216.66M
-12.66%323.34M
13.38%307.51M
Net profit of parent company owners
-11.93%2.01B
-31.09%1.22B
-38.22%609.73M
-36.04%2.39B
-6.29%2.28B
15.74%1.78B
116.17%986.97M
-21.10%3.73B
-31.66%2.44B
-38.14%1.54B
Earning per share
Basic earning per share
-12.79%0.75
-31.34%0.46
-37.84%0.23
-37.76%0.89
-8.51%0.86
11.67%0.67
105.56%0.37
-22.70%1.43
-32.37%0.94
-38.14%0.6
Diluted earning per share
-11.76%0.75
-31.34%0.46
-37.84%0.23
-37.76%0.89
-9.57%0.85
11.67%0.67
105.56%0.37
-22.70%1.43
-32.37%0.94
-38.14%0.6
Other composite income
-155.85%-213.93M
-76.36%112.42M
149.68%91.15M
-70.51%31.86M
-14.95%383.05M
1,180.86%475.61M
31.68%-183.49M
131.39%108.04M
354.75%450.4M
128.03%37.13M
Other composite income of parent company owners
-180.86%-177.25M
-62.70%96.54M
149.48%75.5M
-135.23%-35.44M
-20.51%219.2M
275.82%258.82M
18.44%-152.6M
130.28%100.61M
300.31%275.77M
170.78%68.87M
Other composite income of minority owners
-122.39%-36.68M
-92.67%15.88M
150.69%15.65M
805.34%67.3M
-6.18%163.84M
783.06%216.78M
62.09%-30.89M
162.32%7.43M
546.28%174.63M
9.73%-31.74M
Total composite income
-24.11%2.3B
-34.06%1.66B
-5.74%877.38M
-27.83%2.93B
-5.39%3.04B
34.06%2.52B
154.60%930.77M
-12.45%4.06B
-14.59%3.21B
-28.26%1.88B
Total composite income of parent company owners
-26.73%1.83B
-35.11%1.32B
-17.87%685.23M
-38.64%2.35B
-7.73%2.5B
26.90%2.04B
209.65%834.37M
-12.85%3.83B
-20.87%2.71B
-32.72%1.6B
Total composite income of minority owners
-11.86%471.2M
-29.66%340.82M
99.33%192.14M
157.08%576.1M
7.35%534.59M
75.70%484.54M
0.28%96.4M
-4.90%224.09M
50.41%497.96M
16.83%275.77M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 0.69%30.91B-4.36%20.46B-6.56%10.16B-5.81%41.4B-2.92%30.7B0.22%21.4B4.68%10.87B12.66%43.95B16.91%31.62B25.93%21.35B
Operating revenue 0.69%30.91B-4.36%20.46B-6.56%10.16B-5.81%41.4B-2.92%30.7B0.22%21.4B4.68%10.87B12.66%43.95B16.91%31.62B25.93%21.35B
Other operating revenue -----8.33%218.83M-----14.93%488.71M----3.67%238.71M----66.24%574.48M----57.70%230.25M
Total operating cost -3.04%29.36B-5.93%19.41B-5.70%9.52B-0.15%41.28B2.86%30.28B5.10%20.63B4.19%10.1B11.47%41.35B15.80%29.44B23.52%19.63B
Operating cost 0.70%15.89B-2.20%10.46B-4.10%5.08B-6.80%21.6B-6.70%15.78B-7.60%10.7B-9.67%5.29B14.53%23.17B24.03%16.91B40.23%11.58B
Operating tax surcharges 18.12%233.83M19.37%164.22M37.93%92.44M19.08%271.26M20.13%197.96M26.88%137.57M25.41%67.02M-2.85%227.8M-4.66%164.78M-5.83%108.43M
Operating expense -8.78%6.59B-15.87%4.27B-10.93%2.24B5.90%9.71B11.23%7.23B21.46%5.07B21.59%2.52B0.77%9.17B-0.94%6.5B-0.86%4.18B
Administration expense -0.77%3.14B0.95%2.06B1.13%1B14.28%4.37B20.61%3.17B21.77%2.05B25.25%991.09M18.63%3.83B16.73%2.63B14.66%1.68B
Financial expense 13.03%854.56M7.97%588.83M7.26%280.22M52.04%984.32M99.46%756.08M107.78%545.37M144.12%261.26M39.52%647.4M-3.66%379.07M-7.25%262.47M
-Interest expense (Financial expense) 12.68%1.07B17.60%709.55M22.14%348.09M37.46%1.32B35.63%947.67M37.47%603.38M37.57%285.01M17.17%963.81M10.54%698.73M4.32%438.91M
-Interest Income (Financial expense) -5.31%-279.71M-10.19%-188.97M-10.60%-99.67M-28.66%-363.65M-34.00%-265.61M-44.82%-171.49M-64.43%-90.12M-20.90%-282.63M-13.59%-198.22M-1.56%-118.42M
Research and development -16.07%2.65B-12.77%1.86B-14.38%829.57M1.02%4.35B10.22%3.16B16.81%2.13B19.66%968.87M12.11%4.3B18.60%2.86B16.98%1.83B
Credit Impairment Loss 33.24%-54.47M34.39%-38.04M-32.24%-16.41M-101.82%-131.93M-133.73%-81.58M-153.61%-57.98M-87.81%-12.41M11.68%-65.37M-71.58%-34.9M-54.42%-22.86M
Asset Impairment Loss 85.92%-40.95M77.99%-20.17M144.64%5.89M19.36%-219.74M-210.83%-290.9M-22.93%-91.66M-2,158.02%-13.18M67.17%-272.49M62.00%-93.59M64.04%-74.57M
Other net revenue -46.74%1.56B-54.40%875.35M-40.96%386.54M55.61%3.19B111.83%2.93B137.03%1.92B239.14%654.7M-53.21%2.05B-55.10%1.38B-64.29%809.8M
Fair value change income -113.18%-106.25M-172.90%-282.4M86.36%-20.14M82.89%-427.38M141.76%806.34M127.49%387.37M89.13%-147.61M-809.16%-2.5B-245.96%-1.93B-219.16%-1.41B
Invest income -31.33%1.5B-27.94%1.06B-56.19%335.56M-20.01%3.5B-28.53%2.18B-32.02%1.47B-49.17%765.9M-5.32%4.38B65.13%3.05B85.12%2.17B
-Including: Investment income associates -18.80%1.21B-17.70%841.32M-9.83%330.32M19.06%2.18B22.55%1.5B27.94%1.02B14.94%366.34M2.57%1.84B-7.60%1.22B-3.94%799.02M
Asset deal income -60.10%2.51M-10.94%716.94K185.51%434.1K-95.57%5.56M-95.50%6.3M-52.88%804.99K-173.65%-507.68K914.61%125.6M2,026.44%140.1M-40.15%1.71M
Other revenue -14.78%258.89M-26.05%153.48M29.93%81.22M20.66%463.54M22.92%303.79M40.75%207.54M24.13%62.51M17.18%384.15M38.44%247.15M10.28%147.45M
Operating profit -7.02%3.11B-28.08%1.93B-28.43%1.02B-28.97%3.31B-6.14%3.34B6.17%2.68B61.11%1.43B-26.11%4.66B-24.23%3.56B-24.07%2.53B
Add:Non operating Income -30.29%34.57M19.21%28.86M65.62%9.31M61.10%57.12M195.83%49.59M178.55%24.21M-13.10%5.62M23.72%35.46M-27.44%16.76M-58.50%8.69M
Less:Non operating expense -28.93%70.59M-47.53%26.94M-74.47%12.25M-15.01%100.06M-51.89%99.33M-71.94%51.35M224.95%48M-59.20%117.73M267.97%206.48M311.80%183.02M
Total profit -6.71%3.07B-27.27%1.93B-26.46%1.02B-28.63%3.26B-2.33%3.29B12.89%2.66B57.80%1.38B-24.30%4.57B-27.76%3.37B-28.81%2.35B
Less:Income tax cost -13.40%553.05M-37.49%381.47M-14.16%232.2M-41.06%369.5M4.43%638.65M19.87%610.24M11.16%270.51M-41.21%626.92M-16.37%611.54M-7.55%509.09M
Net profit -5.10%2.52B-24.23%1.55B-29.44%786.22M-26.66%2.9B-3.83%2.65B10.96%2.05B75.70%1.11B-20.67%3.95B-29.87%2.76B-33.06%1.84B
Net profit from continuing operation -5.10%2.52B-24.23%1.55B-29.44%786.22M-26.66%2.9B-3.83%2.65B10.96%2.05B75.70%1.11B-20.67%3.95B-29.87%2.76B-33.06%1.84B
Less:Minority Profit 36.99%507.88M21.36%324.93M38.66%176.49M134.84%508.8M14.66%370.74M-12.93%267.75M-28.33%127.28M-12.48%216.66M-12.66%323.34M13.38%307.51M
Net profit of parent company owners -11.93%2.01B-31.09%1.22B-38.22%609.73M-36.04%2.39B-6.29%2.28B15.74%1.78B116.17%986.97M-21.10%3.73B-31.66%2.44B-38.14%1.54B
Earning per share
Basic earning per share -12.79%0.75-31.34%0.46-37.84%0.23-37.76%0.89-8.51%0.8611.67%0.67105.56%0.37-22.70%1.43-32.37%0.94-38.14%0.6
Diluted earning per share -11.76%0.75-31.34%0.46-37.84%0.23-37.76%0.89-9.57%0.8511.67%0.67105.56%0.37-22.70%1.43-32.37%0.94-38.14%0.6
Other composite income -155.85%-213.93M-76.36%112.42M149.68%91.15M-70.51%31.86M-14.95%383.05M1,180.86%475.61M31.68%-183.49M131.39%108.04M354.75%450.4M128.03%37.13M
Other composite income of parent company owners -180.86%-177.25M-62.70%96.54M149.48%75.5M-135.23%-35.44M-20.51%219.2M275.82%258.82M18.44%-152.6M130.28%100.61M300.31%275.77M170.78%68.87M
Other composite income of minority owners -122.39%-36.68M-92.67%15.88M150.69%15.65M805.34%67.3M-6.18%163.84M783.06%216.78M62.09%-30.89M162.32%7.43M546.28%174.63M9.73%-31.74M
Total composite income -24.11%2.3B-34.06%1.66B-5.74%877.38M-27.83%2.93B-5.39%3.04B34.06%2.52B154.60%930.77M-12.45%4.06B-14.59%3.21B-28.26%1.88B
Total composite income of parent company owners -26.73%1.83B-35.11%1.32B-17.87%685.23M-38.64%2.35B-7.73%2.5B26.90%2.04B209.65%834.37M-12.85%3.83B-20.87%2.71B-32.72%1.6B
Total composite income of minority owners -11.86%471.2M-29.66%340.82M99.33%192.14M157.08%576.1M7.35%534.59M75.70%484.54M0.28%96.4M-4.90%224.09M50.41%497.96M16.83%275.77M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Robot Concept
Robot Concept
Intraday+0.86%
Assisted Reproduction
Assisted Reproduction
Intraday+0.68%
Virus Prevention
Virus Prevention
Intraday+0.60%